On 21st February PACT was advised by Merck, Sharp and Dohme (Australia) of the status of the Sinemet shortage.
MSD requested that we communicate the attached notice to our members.
If you are using Sinemet please read their advice:
In essence, the advice is that the shortage is expected to continue through 2019, and switching to alternative brands or treatments is encouraged.
Footnote April 26th:<